Exhaled Nitric Oxide Is Elevated in Patients With Progressive Systemic Sclerosis Without Interstitial Lung Disease
- 1 May 2001
- journal article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 119 (5), 1449-1454
- https://doi.org/10.1378/chest.119.5.1449
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task ForceEuropean Respiratory Journal, 1997
- Oxidants/antioxidants in idiopathic pulmonary fibrosis.Thorax, 1995
- Nasaily exhaled nitric oxide in humans originates mainly in the paranasal sinusesActa Physiologica Scandinavica, 1994
- Multifunctional role of nitric oxide in inflammationTrends in Endocrinology & Metabolism, 1994
- Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disordersHistopathology, 1994
- Nitric oxide and lung disease.Thorax, 1993
- Cytokines and pulmonary fibrosis.Thorax, 1993
- Fibroblast growth factors in connective tissue disease associated interstitial lung diseaseClinical and Experimental Immunology, 1992
- Evaluation and management of scleroderma lung disease using bronchoalveolar lavageAmerican Journal Of Medicine, 1990
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986